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1. INTRODUCTION 
The organisation of DNA in eukaryotic nuclei is only 
partially understood. The basic repeating subunit of 
chromatin, the nucleosome, has been extensively 
studied and its structure solved by X-ray 
crystallography. This, however, has shed little light on 
how higher order structures are formed. Nuclear 
chromatin is heterogeneous in structure as defined by a 
number of criteria. For example, its conformation can 
be probed and classified into categories according to its 
nuclease sensitivity. Regions of the genome containing 
active genes are more sensitive to nuclease digestion 
than non-transcribed regions. Heterogeneity is also 
detectable by microscopy. Transcriptionally inert 
regions of the nucleus stain differentially and hence are 
termed heterochromatin. The underlying molecular 
mechanisms for these differences are unknown. 
At the DNA level, the genome can be divided into 
two categories containing methylated or non- 
methylated DNA. In animal genomes, the modified 
base S-methylcytosine (mSC) is restricted to the 
dinucleotide CpG. In mammals approximately 70% of 
all CpGs are methylated, the remaining CpGs being 
non-methylated. DNA containing non-methylated 
CpGs comprises about 1-2‘70 of the genome. This 
means that the vast majority of the chromatin is 
associated with methylated DNA. In this review we 
discuss the evidence that differential methylation can be 
a determinant of higher order structure. 
The first indication that methylated DNA was in a 
specific chromatin structure came from experiments by 
Razin and Cedar [ 1 J. Mouse L cell nuclei were digested 
with micrococcal nuclease (MNase) and the m5C con- 
tent of the solubilised chromatin analysed. It was 
observed that m5C in chromatin was relatively resistant 
to degradation by MNase. After extensive digestion, 
50% of the DNA remained unsolubilised, but this frac- 
tion contained over 70% of the total mSC. 
In a subsequent paper Solage and Cedar [2] 
characterised the kinetics of chromatin digestion and 
the copy number of associated DNA sequences more 
thoroughly. Nuclear DNA of L cells was labelled in vivo 
at thymidine or m5C residues and the nuclei were then 
isolated. After varying degrees of digestion with 
MNase, the amount of solubilised thymidine and m5C 
was analysed. Early time points showed that although 
thymidine was readily released, m5C was not detected 
until 15% of the genomic DNA had been solubilised. In 
addition, m5C was released with slower kinetics than 
thymidine. These experiments showed that DNA con- 
taining msC is organised in chromatin that is relatively 
resistant to nucleases such as MNase. 
Keshet and Cedar [3] have provided a direct 
demonstration that methylation can cause DNAs to 
adopt a nuclease insensitive structure. When 
methylated constructs were transfected into L cells and 
integrated into the genome, it was shown that they were 
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nucleases. This showed that artificially introduced 
DNAs were abIe to adopt a chromatin structure 
specified by their methylation status. 
In an attempt to understand the mechanism underly- 
ing the relative nuclease insensitivity of m5C-containing 
chromatin, Ball et al. [4] fractionated nucleosomes on 
agarose gels after MNase treatment. Under the condi- 
tions used, nucIeosomes could be resolved into histone 
M 1 -containing and H 1 -deficient fractions. Using an an- 
tibody directed against msC, they assayed for the 
presence of this modified base in the DNA associated 
with the different classes of nucleosomes. They observ- 
ed that nucleosomes which were associated with histone 
H 1 were significantly enriched for m5C. At least 80% of 
the m5C was Iocated in nucleosomes contairling HI. 
Nucleosomes which lacked H 1 had levels of mSC reduc- 
ed to about 1.6-2.3-foId below the expected level. They 
proposed on the basis of this evidence that the preferen- 
tial association of HI with nucleosomes containing 
methylated DNA may contribute to alterations in 
nuclease sensitivity. 
In our Iaboratory, Antequera et al. [5] have shown 
that the accessibility of sites in nuclei for CpG enzymes 
depends on their methylation status. This result was 
unexpected because these enzymes normally cut naked 
DNA irrespective of methylation. On digestion of bulk 
chromatin, it was demonstrated that MspI and TfhI are 
preferentially blocked from cutting methylated sites 
under conditions of complete digestion. The simplest 
explanation of these results is that there are factors 
which bind to m*CpGs, preventing cleavage of methyl- 
ated sites. In contrast, bulk chromatin is extensively 
cleaved by enzymes which do not contain a CpG in their 
recognition sequence. This suggests the observed dif- 
ferential sensitivity was specific to m%pGs. 
3. CpG ISLAND CHROMATIN 
The chromatin structure of non-methylated CpGs 
has been studied by utilising some specific properties of 
CpG islands. These are non-methylated regions of 
DNA about 0.5-2 kb long which are characteristically 
GC-rich and which contain CpGs at the frequency ex- 
pected from the base composition [6]. They are found 
associated with the 5’ domains of all housekeeping 
genes and a small proportion of tissue specific genes, 
Since the CpG islands usually contain the promotors of 
housekeeping genes which are by definition transcrip- 
tionally active, it follows that islands should represent 
‘active chromatin’. In agreement of this hypothesis, 
analysis of two X-linked genes, hypoxanthine 
phosphoribosyltransferase (HPRT) and glucose 
6-phosphate dehydrogenase (G6PD), has shown that 
their CpG isIands are hypersensitive to nucleases [7] 
such as MwI, DNase 1 and St nuclease on the active X 
chromosome (X,). Tazi and Bird [8] used the sensitivity 
of CpG islands to CpG enzymes in order to develop a 
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method for isolating CpG island chromatin. The 
method was based on the earlier observation of Ante- 
quera et al. [5] that complete digestion of nuclei with 
CpG enzymes gives short oligonucleosomes derived 
from CpG islands, but leaves bulk chromatin intact. 
This means that transcriptionally active chromatin can 
be very highly enriched and its protein composition 
analysed. The approach circumvented a major 
drawback of previous studies on active chromatin, since 
complete rather than partial nuclease digestions were 
used and cross-contamination was therefore minimal. 
On analysis of the digestion products, several dif- 
ferences between CpG island chromatin and bulk 
chromatin were apparent. In addition to the short 
oligonucleosomes observed on end-labelling of the CpG 
enzyme released fraction, a fast migrating species of 
DNA, below mononucleosomal size, was observed. The 
very small fragments were not observed on digestion of 
bulk chromatin, implying that they were specific to 
CpG island chromatin. The most likely explanation for 
the occurrence of these fragments was the presence of a 
nucleosome-free region in most, if not all, constitutive- 
ly transcribed CpG islands. This was confirmed by 
Southern hybridisation of the fractionated fragments to 
a c$os probe. The results showed that fragments in this 
fraction came from a region of the c-fos promoter 
which coincided with a DNAse I hypersensitive site, and 
therefore most probably lacks a nucleosome. 
To investigate the associated proteins, nuclear diges- 
tion products of CpG and non-CpG enzymes were frac- 
tionated away from uncut chromatin and then enriched 
for histones. On analysis of the protein components it 
was striking that the nucleosomes obtained by CpG en- 
zymes were deficient in histone HI (approximately 10% 
of the level observed for bulk chromatin). In addition to 
this, histones H3 and H4 were found to be highly 
acetylated in comparison to those in bulk chromatin. 
Acetylation of these two histones has been previously 
associated with active chromatin structures. For exam- 
ple, Hebbes et al. [9] have shown that actively transcrib- 
ed regions of chromatin can be significantly enriched by 
immunoprecipitation using an anti-acetylated H4 an- 
tibody. In summary it seems most likely that the 
presence of highly acetylated H3 and H4, deficiency of 
H 1 and a missing nucleosome in CpG islands may all be 
a consequence of the presence within these sequences of 
constitutively active promoters. 
4, EFFECTS OF DNA METHYLATION IN 
HETEROCHROMATIN 
Different chromatin structures can be distinguished 
under the light and electron microscopes. Densely stain- 
ing regions in the nucleus correspond to 
heterochromatin, which may be either constitutive or 
facultative. Constitutive heterochromatin often con- 
rains highly repeated DNA sequences, whereas 
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facultative heterochromatin arises from inactivation of 
previously euchromatic regions. One of the best known 
examples of facultative heterochromatin is the inactiva- 
tion of one X chromosome during development of the 
mammalian female. There is reason to believe that 
DNA methylation is relevant to the formation of both 
facultative and constitutive heterochromatin. 
In early embryogenesis, one of the X chromosomes 
undergoes inactivation by heterochromatisation and the 
CpG islands become methylated [lo]. At this stage the 
chromosome is visible cytologically in metaphase 
spreads of female chromosomes as a densely staining 
structure known as the Barr body. Concurrent with in- 
activation of the X chromosome is a shift of its replica- 
tion time to late in the S phase of the cell cycle. There 
is evidence that methylation may play a role in the shift 
of the replication time of the chromosome [ll]. When 
cells containing an inactive X chromosome (Xi), are 
grown in 5azacytidine, a potent inhibitor of DNA 
methylation, the inactive X becomes progressively 
demethylated and its replication time shifts to early S 
phase. This demonstrates that artificiaI a!teration of 
chromosomal methylation levels can lead to changes in 
replication timing. 
Further support for the idea that DNA methylation is 
involved in determining replication timing comes from 
studies on satellite DNA. These sequences which are 
present at very high copy number in most vertebrates 
are normally heavily methylated. For example, the 
mouse major satellite comprises a 234 bp repeat unit 
reiterated approximately one million times per haploid 
genome in Mus mtrsculus. Since a repeat unit contains 
8 mSCpGs on average, it follows that approximately 
50% of mouse msC is located in satellite. In keeping 
with this, staining with anti-msC antibodies localises to 
the centromeric C-banding regions of constitutive 
heterochromatin in mouse [12], which is also the loca- 
tion of the major satellite sequences. 
Although the major satellite is normally heavily 
methylated and late replicating, it is undermethylated at 
early stages in development. In F9 embryonal car- 
cinoma cells, which are derived from an early 
developmental stage, the replication time of the 
hypomethylated major satellite is shifted to early S 
phase [IS]. Treatment of the RAG mouse fibroblast cell 
line, in which the satellite is hypermethylated, with 
5-azacytidine causes a dramatic shift of the satellite 
replication time from very late to the middle of S phase. 
Thus as in the case of Xi, the evidence suggests that 
methylation plays a causal role in keeping these se- 
quences late replicating. 
Another characteristic in common between the Xi 
and satellite heterochromatin is reduced sensitivity to 
nucleases. For example, the Xi is less sensitive to 
nuclease digestion than the X, indicating an alternative 
chromatin structure. Using DNase I directed nick 
translation on specially prepared metaphase spreads, 
Kerem et al. [7] were able to differentiate the Xa from 
the Xi due to extensive DNase I sensitive regions in the 
former. By comparison, the Xi was largely untouched 
by this nuclease except for a small region known to be 
early replicating. It has also been shown by Jablonka et 
al. [ll] that the relative insensitivity of the Xi to 
nuclease digestion could be reversed by inhibiting 
methylation with 5azacytidine. This treatment increas- 
ed the nuclease sensitivity of Xi to levels comparable 
with Xa. 
The highly methylated major satellite of mouse is 
also nuclease insensitive. Solage and Cedar [2], in their 
study of MNase digestion kinetics and m5C release, 
analysed the types of sequences that were digested, 
Utilising Cot analysis, they showed that the fraction of 
the chromatin most resistant to nuclease digestion 
originated from the highly methylated satellite and con- 
tained approximately 50% of the msC. In contrast to 
the Xi results, however, these sequences were not 
nuclease sensitive in F9 cells although they were 
hypomethylated. Moreover, creation of the 
undermethylated state with 5-azacytidine did not result 
in increased nuclease sensitivity. The differences in the 
nuclease sensitivity of the hypomethylated X and 
undermethylated satellite may reflect differences in 
transcriptional activity. Transcription of activated 
genes on the hypomethylated X would be expected to 
maintain the chromatin in an active conformation. The 
satellite sequences, being non-transcribed, may adopt 
an inactive chromatin structure which is resistant to 
nucleases regardless of methylation. 
5. CpG ACCESSIBILITY AT SPECIFIC 
SEQUENCES 
CpG islands are normally non-methylated irrespec- 
tive of transcriptional activity. There are however a few 
exceptions to this general rule. In mammalian females, 
one of the two X chromosomes is inactivated as part of 
the dosage compensation mechanism and the island 
genes are then methylated. In addition, extensive 
methylation of some CpG islands is observed in tissue 
culture cell lines, especially those which have been in 
culture for many years [14]. In keeping with the results 
described in the previous section, the inaccessibility of 
methylated DNA in chromatin to nucleases is observed 
at specific sequences. Wolf and Migeon [lS] analysed 
nuclease sensitivity of DNA sequences urrounding the 
X-linked HPRT and G6PD genes. They found that se- 
quences on X, were hypersensitive to digestion at MspI 
sites. In contrast, sequences on the Xi, in which the 
CpG islands are methylated and inactive, were not 
digested at all. Similar blockage of MspI &es in nuclei 
was found by comparing the accessibility of specific 
methylated and non-methylated MspI sites in the (Y- 
globin locus [S]. The cr-globin CpG island in HeLa cells 
has become extensively methylated during passage in 
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tissue culture. It was shown that none of the rnethylated 
CpGs were cleaved significantly in nuclei, whereas the 
unmethylated sites at the locus were cut. This and above 
examples demonstrated that specific methylated sites in 
nuclei are resistant to MspI. This contrasts with the 
relatively unhindered access of non-CpG enzymes to 
regions of methylated DNA. The conclusion is that 
r&-containing DNAs adopt a chromatin structure 
which protects the n?CpGs, but not neighbouring se- 
quences, from nuclease digestion. 
This conclusion is further supported by studies on 
nuclease sensitivity of marsupial inactive X 
chromosomes [16]. Unlike placental mammals, X 
chromosome inactivation and heterochromatisation in 
marsupials is not associated with CpG island methyla- 
tion. Correspondingly the Xa and Xi are equally accessi- 
ble to MspI, showing that heterochromatinisation alone 
is not sufficient to block MspI cleavage. Methylatiorl of 
CCGG sites, as occurs in placental mammals, is also re- 
quired. 
mouse L cells, the methylated constructs assemble into 
6. TRANSCRIPTIONAL INWIBITION BY m’CpGs 
There is a strong correlation between the presence of 
DNA methylation at promoter sequences and transcrip- 
tional inhibition. For example, DNA from the Xi is not 
able to transform HPRT - cells to HPRT’ [17]. 
However, DNA from the Xa, or from an Xi 
chromosome which had previously been treated with 
S-azacytidine can transform the recipient cells to 
HPRT + . Inhibition of transcription by methylation has 
also been confirmed by in vitro methylation of specific 
genes and transfection of these constructs into cells. 
Busslinger et al. [ 181 showed that complete methylation 
of the human y-globin gene could inhibit transcription. 
In addition, these authors showed that methylation in 
the 5’ promoter region was sufficient to prevent 
transcription, since methylation outside this region had 
no inhibitory effect. Murray and Grosveld [ 191 extend- 
ed these results to show that the inhibition was not 
dependent on methylation of specific sites in the pro- 
moter. The presence of m’CpGs in different regions of 
the promoter was sufficient $0 inhibit transcription. 
There is a variety of cvidcnce which suggests that 
methylation exerts its effects through alterations in 
chromatin structure rather than by interfering with the 
transcription machinery directly. The simplest model 
invokes a protein or proteins which can bind specifical- 
ly to methylated DNA thereby excluding transcription 
factors. Binding of such a protein would also be respon- 
sible for the other effects associated with DNA 
methylation, such as nuclease resistance and late 
replication. 
Evidence for the above model is accumulating from 
several directions. For example, upon trausfection of 
various methylated and non-methylated constructs into 
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nuclease insensitive chromatin [3]. 
Furthermore, Buschhausen et al. [20] have shown 
that inhibition of transcription of f?paII methylated 
thymidine kinase (TK) constructs was an indirect effect. 
On assaying the TK RNA levels from the injected 
methylated and non-methylated constructs, methylated 
TIC was just as transcriptional active as a mock 
methylated control. After 8 h, however, a sharp drop in 
expression levels was observed from the methylated 
construct. This timing coincided with the assembly of 
transfected DNAs into chromatin. If constructs were 
assembled in vitro into chromatin prior to injection, 
transcription from the methylated template was in- 
hibited immediately. Thus, in this case, methylation 
alone is not sufficient to inhibit transcription. Interac- 
tion with nuclear components is first required for 
transcriptional inhibition to be observed. 
7. METWYLATED DNA BINDING PROTEINS 
With the above experiments in mind, we have at- 
tempted to identify proteins that bind specifically to 
methylated DNA and may therefore mediate the effects 
of methylation on chromatin and transcription. 
Although a methylated DNA binding protein, MDBP, 
has been previously described [21] it is highly sequence- 
specific. Due to the sequence complexity of methylated 
DNA it seems unlikely that a protein like MDBP plays 
a general role in exerting the effects of methylation. We 
have identified a nuclear protein from mouse which is 
characterised by its ability to complex specifically with 
DNA containing multiple mSCpG sites independently 
of the sequence context of those sites [22]. This protein, 
which we have named ‘methylated CpG binding pro- 
tein’ (MeCP), is by virtue of its relaxed sequence 
specificity and ubiquitous tissue distribution, a good 
candidate for mediator of the effects of methylation. 
MeCP is found in nuclear extracts from various mam- 
mals that have been tested and has been shown to re- 
quire a minimum of 15 m’CpGs per substrate molecule 
for strong binding. It is found only at very low levels in 
F9 and PC13 cell lines, both of which are embryonically 
derived. Interestingly, Antequera et al. [5] found that 
the level of mSCpG protection was reduced in PC13 
cells, establishing a correlation between levels of MeCP 
and degree of m’CpG protection. These studies also 
established that binding of MeCP to methylated DNA 
in vitro reduces the accessibility of methylated MspI 
sites. 
There is also good evidence that MeCP is involved in 
methylation-mediated transcriptional inhibition. Boyes 
and Bird [23] have provided evidence that MeCP can in- 
hibit transcription from methylated promotors both in 
vitro and in vivo. The fact that transcription of 
methylated templates could be restored by addition of 
only methylated competitor DNAs which are bound 
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strongly by MeCP, constituted strong evidence that this [6] Bird, A.P. (1986) Nature 321, 299-213. 
[7] Kerem, B.S., Goiten, R., Richler, C., Marcus, M. and Cedar, 
H. (1983) 304, 88-90. 
protein was inhibiting transcription. Further to this, 
transcriptional inhibition feom methylated templates 
was not observed in an IMeCP-deficient cell line. In 
conclusion, the effects of DNA methylation on 
chromatin and transsription can be mimicked by the 
protein MeCP. An intriguing possibility is that all of the 
primary biological consequences of CpG-methylation 
are mediated by the interaction of MeCP or related pro- 
teins with DNA. Further work will be required to test 
these points sritisally. 
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